MEDICLINIC INTERNATIONAL PLC - Notification of major interest in Mediclinic International plc shares

Release Date: 20/11/2018 15:00
Code(s): MEI
 
Wrap Text
Notification of major interest in Mediclinic International plc shares

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI  
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")

20 November 2018

Notification of Major Interest in Mediclinic International plc shares

1a. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are at-                          Mediclinic International plc
tached:

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights                                                           X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify):

3. Details of person subject to the notification obligation
Name                                                    Coronation Asset Management (Pty) Ltd acting as
                                                        discretionary investment manager on behalf of
                                                        managed portfolios.
City and country of registered office (if applicable)   Cape Town, South Africa

4. Full name of shareholder(s) (if different from 3.)
Name                                                    N/A
City and country of registered office (if applicable)

5. Date on which the threshold was crossed or
reached:                                                20/11/2018

6. Date on which issuer notified (DD/MM/YYYY):          20/11/2018
                                                                                                     
7. Total positions of person(s) subject to the notification obligation
                                                       
                          % of voting rights at-       % of voting rights             Total of both in %        Total number of
                          tached to shares (to-        through financial instru-      (8.A + 8.B)               voting rights of is-
                          tal of 8. A)                 ments                                                    suer                                                                                                                     
                                                       (total of 8.B 1 + 8.B 2)
Resulting situation
on the date on which
threshold was                    4.06%                          4.06%                                                737 243 810
crossed or reached
Position of previous
notification (if                 3.98%                                                      3.98%
applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or
reached
A: Voting rights attached to shares

Class/type of             Number of voting rights                            % of voting rights
shares
ISIN code (if possible)   Direct                 Indirect                    Direct                   Indirect
                          (Art 9 of Directive    (Art 10 of Directive        (Art 9 of Directive      (Art 10 of Di-
                          2004/109/EC)           2004/109/EC)                2004/109/EC) (DTR5.1)    rective
                          (DTR5.1)               (DTR5.2.1)                                           2004/109/EC)
                                                                                                      (DTR5.2.1)
GB00B8HX8Z88              29 909 882                                                4.06%

SUBTOTAL 8. A                            29 909 882                                              4.06%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
                                                                                
Type of financial in-     Expiration     Exercise/                Number of voting rights      % of voting rights
strument                  date           Conversion Period        that may be acquired if            
                                                                  the instrument is
                                                                  exercised/converted.
                                                                         
                                         SUBTOTAL 8. B 1
                                                                                                                       
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive
2004/109/EC (DTR5.3.1.1 (b))
                                                          
Type of financial    Expiration        Exercise/            Physical or       Number of
instrument           date              Conversion Pe-       cash              voting rights    % of voting rights
                                       riod                 settlement                            

                                                            SUBTOTAL
                                                            8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not
control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity         X
(please add additional rows as necessary)
                                                                     
Name                                      % of voting rights         % of voting rights
                                          if it equals or is         through financial            Total of both if it
                                          higher than the            instruments if it            equals or is higher
                                          notifiable thresh-         equals or is higher          than the notifiable
                                          old                        than the notifiable          threshold
                                                                     threshold
                                                                                                               
Coronation Fund Managers Ltd
Coronation Investment Management
SA (Pty) Ltd
Coronation Asset Management (Pty)              4.06%                                                    4.06%
Ltd

10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional information
                                                                                                                     
Place of completion         Cape Town, South Africa
Date of completion          20/11/2018

Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the
JSE in South Africa and the NSX in Namibia.

For further information, please contact:

Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569

Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181

Media queries
FTI Consulting
Brett Pollard/Debbie Scott – UK
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
Date: 20/11/2018 03:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story